GSA Capital Partners’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,601
| Closed | -$346K | – | 1707 |
|
|
2020
Q3 | $346K | Buy |
5,601
+5,151
| +1,145% | +$318K | 0.06% | 641 |
|
|
2020
Q2 | $40K | Sell |
450
-1,636
| -78% | -$145K | 0.02% | 544 |
|
|
2020
Q1 | $233K | Buy |
+2,086
| New | +$233K | 0.06% | 655 |
|
|
2019
Q4 | – | Sell |
-152
| Closed | -$52K | – | 1817 |
|
|
2019
Q3 | $52K | Buy |
+152
| New | +$52K | 0.01% | 1319 |
|
|
2019
Q2 | – | Sell |
-545
| Closed | -$869K | – | 1815 |
|
|
2019
Q1 | $869K | Buy |
545
+37
| +7% | +$59K | 0.09% | 367 |
|
|
2018
Q4 | $949K | Hold |
508
| – | – | 0.11% | 240 |
|
|
2018
Q3 | $1.2M | Buy |
+508
| New | +$1.2M | 0.07% | 559 |
|
|
2018
Q2 | – | Sell |
-699
| Closed | -$1.98M | – | 2000 |
|
|
2018
Q1 | $1.98M | Buy |
+699
| New | +$1.98M | 0.11% | 294 |
|
|
2017
Q4 | – | Sell |
-191
| Closed | -$541K | – | 1890 |
|
|
2017
Q3 | $541K | Buy |
+191
| New | +$541K | 0.04% | 918 |
|
|
2016
Q4 | – | Sell |
-185
| Closed | -$463K | – | 2018 |
|
|
2016
Q3 | $463K | Buy |
185
+11
| +6% | +$27.5K | 0.02% | 1105 |
|
|
2016
Q2 | $532K | Sell |
174
-242
| -58% | -$740K | 0.03% | 1032 |
|
|
2016
Q1 | $1.32M | Buy |
416
+247
| +146% | +$784K | 0.08% | 397 |
|
|
2015
Q4 | $867K | Sell |
169
-343
| -67% | -$1.76M | 0.04% | 802 |
|
|
2015
Q3 | $1.63M | Buy |
512
+363
| +244% | +$1.15M | 0.08% | 364 |
|
|
2015
Q2 | $596K | Sell |
149
-140
| -48% | -$560K | 0.02% | 1238 |
|
|
2015
Q1 | $1.16M | Sell |
289
-66
| -19% | -$264K | 0.05% | 744 |
|
|
2014
Q4 | $1.74M | Buy |
355
+73
| +26% | +$358K | 0.12% | 186 |
|
|
2014
Q3 | $1.15M | Sell |
282
-21
| -7% | -$85.3K | 0.06% | 409 |
|
|
2014
Q2 | $1.22M | Buy |
303
+177
| +140% | +$715K | 0.06% | 539 |
|
|
2014
Q1 | $571K | Sell |
126
-134
| -52% | -$607K | 0.04% | 694 |
|
|
2013
Q4 | $912K | Buy |
260
+132
| +103% | +$463K | 0.07% | 423 |
|
|
2013
Q3 | $527K | Buy |
128
+16
| +14% | +$65.9K | 0.04% | 752 |
|
|
2013
Q2 | $444K | Buy |
+112
| New | +$444K | 0.05% | 619 |
|